---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-22-008666"
form_type: "8-K"
ticker: "COSM"
cik: "0001474167"
company_name: "Cosmos Health Inc."
filed_at: "2022-11-16T23:59:59+00:00"
generated_at: "2026-06-21T17:25:45.356384+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Cosmos Health (COSM) faces Nasdaq delisting; Q3 2022 revenue $12M, net loss $2M

## Summary
- Received Nasdaq delisting notice; suspension expected Nov 21, 2022; company appeals and seeks reverse stock split at Dec 2 shareholder meeting.
- Q3 revenue $12.0M vs $13.6M a year ago; gross margin fell to 14.8% from 17.3%.
- Net loss $1.97M; adjusted EBITDA $0.5M vs $1.2M in 3Q21.
- Closed $7.5M public offering of 62.5M shares and 125M warrants at $0.12/unit.
- Entered LOI to acquire ZipDoctor telemedicine platform and agreement to acquire CANA S.A.

## SEC filing metadata
- accession: 0001477932-22-008666
- form_type: 8-K
- ticker: COSM
- cik: 0001474167
- company_name: Cosmos Health Inc.
- filed_at: 2022-11-16T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1474167/000147793222008666/0001477932-22-008666-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1474167/000147793222008666/cosm_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-22-008666
- JSON: https://secwatch.observer/filing/0001477932-22-008666.json
- Plain text: https://secwatch.observer/filing/0001477932-22-008666.txt

## Key facts
- Earnings Releases
  Cosmos Health Inc. reported third quarter 2022 results: revenue $12.0M.
  - Period: third quarter 2022
  - Revenue: $12.0M
  - Result: reported results
  source text: · Revenues were $12.0M versus $13.6M in 3Q21.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1474167/000147793222008666/0001477932-22-008666-index.htm
- Listing & Compliance Notices
  Cosmos Health Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5810(c)(3)(A)(ii)).
  - Exchange: nasdaq
  - Notice: noncompliance notice
  - Deficiency: minimum bid price
  - Rules: 5810(c)(3)(A)(ii)
  source text: November 10, 2022, Cosmos Holdings Inc. (the “Company”) received a non-compliance letter from the Nasdaq Stock Market for its failure to maintain a minimum closing bid price of $0.10 per share for ten (10) consecutive business days in accordance with Nasdaq Listing Rule 5810(c)(3)(A)(ii). Pursuant to a prior non-compliance letter from Nasdaq dated July 26, 2022, the Company had until January 23, 2023 to regain compliance by the closing bid price of the Company’s common stock being at least $1.00 per share for ten (10) consecutive trading days. The Staff has determined to suspend trading of the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1474167/000147793222008666/0001477932-22-008666-index.htm
- Listing & Compliance Notices
  Cosmos Health Inc. received a nasdaq delisting notice notice regarding minimum bid price.
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  source text: Form 25-NSE with the SEC to remove the Company’s securities from listing and registration on the Nasdaq Stock Market. Although there is no assurance, we expect that the shareholder proposal at our scheduled December 2, 2022 Annual Shareholders Meeting, for which we have obtained a quorum, to provide the Board of Directors with the discretion to effect a reverse stock split, will enable us to regain compliance with Nasdaq’s minimum bid-price requirement for continued listing on the Nasdaq Capital Market.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1474167/000147793222008666/0001477932-22-008666-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.